Seki N - Search Results

1

Versican expression in human cervical cancer.

Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Nakamura K, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. Eur J Cancer. 2007 Jun;43(9):1460-6. doi: 10.1016/j.ejca.2007.02.007. Epub 2007 Apr 18. Eur J Cancer. 2007. PMID: 17446061

2

Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.

Kodama J, Shinyo Y, Hasengaowa, Kusumoto T, Seki N, Nakamura K, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. Oncol Rep. 2005 Jul;14(1):89-92. Oncol Rep. 2005. PMID: 15944773

3

Prognostic significance of the thymidine phosphorylate/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer.

Kodama J, Shinyo H, Kusumoto T, Seki N, Nakamura Y, Nakamura K, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):81-85. doi: 10.1016/j.ejogrb.2004.11.011. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16259080 No abstract available.

4

Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.

Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. Gynecol Oncol. 2007 Jun;105(3):757-61. doi: 10.1016/j.ygyno.2007.02.019. Epub 2007 Apr 12. Gynecol Oncol. 2007. PMID: 17433424

5

Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.

Kuramoto H, Hongo A, Liu YX, Ojima Y, Nakamura K, Seki N, Kodama J, Hiramatsu Y. Kuramoto H, et al. Among authors: seki n. Acta Med Okayama. 2008 Aug;62(4):251-9. doi: 10.18926/AMO/30944. Acta Med Okayama. 2008. PMID: 18766208 Free article.

6

Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.

Kodama J, Seki N, Masahiro S, Kusumoto T, Nakamura K, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. J Surg Oncol. 2010 Apr 1;101(5):413-7. doi: 10.1002/jso.21499. J Surg Oncol. 2010. PMID: 20127891

7

Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.

Kusumoto T, Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y. Kusumoto T, et al. Among authors: seki n. Oncol Rep. 2010 Apr;23(4):917-25. doi: 10.3892/or_00000715. Oncol Rep. 2010. PMID: 20204274

8

Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.

Kodama J, Kusumoto T, Nakamura K, Seki N, Hongo A, Hiramatsu Y. Kodama J, et al. Among authors: seki n. Gynecol Oncol. 2011 Sep;122(3):491-4. doi: 10.1016/j.ygyno.2011.05.038. Epub 2011 Jun 24. Gynecol Oncol. 2011. PMID: 21703671

9

The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence.

Nakamura K, Joja I, Nagasaka T, Fukushima C, Kusumoto T, Seki N, Hongo A, Kodama J, Hiramatsu Y. Nakamura K, et al. Among authors: seki n. Gynecol Oncol. 2012 Dec;127(3):478-83. doi: 10.1016/j.ygyno.2012.07.123. Epub 2012 Aug 11. Gynecol Oncol. 2012. PMID: 22892362

10

The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer.

Nakamura K, Joja I, Fukushima C, Haruma T, Hayashi C, Kusumoto T, Seki N, Hongo A, Hiramatsu Y. Nakamura K, et al. Among authors: seki n. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):52-60. doi: 10.1007/s00259-012-2240-7. Epub 2012 Sep 12. Eur J Nucl Med Mol Imaging. 2013. PMID: 22968401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters